The Effect of Treatment with Mesenchymal Stem Cells on HbA1c and Insulin Requirement in Diabetic Patients: A Systematic Review and Meta-analysis
Background and aim: This study explores the use of mesenchymal stem cells (MSCs) as a potential therapeutic option for diabetes treatment, addressing the increasing global prevalence of the condition, the lack of glucose control, the need for insulin injections, patient quality of life, and associat...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
International Journal of Scientific Research in Dental and Medical Sciences (IJSRDMS)
2025-06-01
|
| Series: | International Journal of Scientific Research in Dental and Medical Sciences |
| Subjects: | |
| Online Access: | http://www.ijsrdms.com/article_224002_344a3dd39c5f2107636934a8d8fd93fe.pdf |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849422352032464896 |
|---|---|
| author | Parsa Eshragh Abad Shapori Maryam Fathi |
| author_facet | Parsa Eshragh Abad Shapori Maryam Fathi |
| author_sort | Parsa Eshragh Abad Shapori |
| collection | DOAJ |
| description | Background and aim: This study explores the use of mesenchymal stem cells (MSCs) as a potential therapeutic option for diabetes treatment, addressing the increasing global prevalence of the condition, the lack of glucose control, the need for insulin injections, patient quality of life, and associated side effects. It investigates the impact of MSC treatment on HbA1c levels and insulin requirements in patients with diabetes.
Material and methods: The present study included 13 RCT studies from international databases (PubMed, EMBASE, Web of Science, and Cochrane Library) up to April 30, 2025, identified using relevant keywords and based on study inclusion and exclusion criteria. The statistical analysis was performed using Stata/MP v17 as a fixed-effects model.
Results: HbA1c levels in the group receiving MSC therapy were significantly lower than in the placebo group, with the mean changes of HbA1c being -0.72 (MD: -0.72; 95% CI, -0.95,-0.50). The mean changes of FPG in T1DM were -29.65 (MD: -29.65; 95% CI, -47.2, -12.28), and in T2DM were -0.68 (MD: -0.68; 95% CI, -1.56, -0.20). The test of group differences showed that the effectiveness of MSC therapy on both types of diabetes (T1DM and T2DM) in terms of C-peptide levels is similar (p = 0.08).
Conclusions: A decrease in HbA1c levels, a decrease in fasting blood sugar, and an increase in C-peptide levels were observed after treatment with mesenchymal stem cells compared to the placebo group, indicating that mesenchymal stem cells can effectively affect the treatment process of diabetes. |
| format | Article |
| id | doaj-art-2afcc0e369a5418c86dc6a9d2b153549 |
| institution | Kabale University |
| issn | 2676-5497 2676-5373 |
| language | English |
| publishDate | 2025-06-01 |
| publisher | International Journal of Scientific Research in Dental and Medical Sciences (IJSRDMS) |
| record_format | Article |
| series | International Journal of Scientific Research in Dental and Medical Sciences |
| spelling | doaj-art-2afcc0e369a5418c86dc6a9d2b1535492025-08-20T03:31:10ZengInternational Journal of Scientific Research in Dental and Medical Sciences (IJSRDMS)International Journal of Scientific Research in Dental and Medical Sciences2676-54972676-53732025-06-0172889510.30485/ijsrdms.2025.532144.1664224002The Effect of Treatment with Mesenchymal Stem Cells on HbA1c and Insulin Requirement in Diabetic Patients: A Systematic Review and Meta-analysisParsa Eshragh Abad Shapori0Maryam Fathi1Faculty of Medicine, Shahrekord University of Medical Sciences, Shahrekord, IranFaculty of Health Sciences of Sorbonne, Antoine Béclère hospital, Paris, FranceBackground and aim: This study explores the use of mesenchymal stem cells (MSCs) as a potential therapeutic option for diabetes treatment, addressing the increasing global prevalence of the condition, the lack of glucose control, the need for insulin injections, patient quality of life, and associated side effects. It investigates the impact of MSC treatment on HbA1c levels and insulin requirements in patients with diabetes. Material and methods: The present study included 13 RCT studies from international databases (PubMed, EMBASE, Web of Science, and Cochrane Library) up to April 30, 2025, identified using relevant keywords and based on study inclusion and exclusion criteria. The statistical analysis was performed using Stata/MP v17 as a fixed-effects model. Results: HbA1c levels in the group receiving MSC therapy were significantly lower than in the placebo group, with the mean changes of HbA1c being -0.72 (MD: -0.72; 95% CI, -0.95,-0.50). The mean changes of FPG in T1DM were -29.65 (MD: -29.65; 95% CI, -47.2, -12.28), and in T2DM were -0.68 (MD: -0.68; 95% CI, -1.56, -0.20). The test of group differences showed that the effectiveness of MSC therapy on both types of diabetes (T1DM and T2DM) in terms of C-peptide levels is similar (p = 0.08). Conclusions: A decrease in HbA1c levels, a decrease in fasting blood sugar, and an increase in C-peptide levels were observed after treatment with mesenchymal stem cells compared to the placebo group, indicating that mesenchymal stem cells can effectively affect the treatment process of diabetes.http://www.ijsrdms.com/article_224002_344a3dd39c5f2107636934a8d8fd93fe.pdfdiabetes mellitusinsulinmesenchymal stem cells |
| spellingShingle | Parsa Eshragh Abad Shapori Maryam Fathi The Effect of Treatment with Mesenchymal Stem Cells on HbA1c and Insulin Requirement in Diabetic Patients: A Systematic Review and Meta-analysis International Journal of Scientific Research in Dental and Medical Sciences diabetes mellitus insulin mesenchymal stem cells |
| title | The Effect of Treatment with Mesenchymal Stem Cells on HbA1c and Insulin Requirement in Diabetic Patients: A Systematic Review and Meta-analysis |
| title_full | The Effect of Treatment with Mesenchymal Stem Cells on HbA1c and Insulin Requirement in Diabetic Patients: A Systematic Review and Meta-analysis |
| title_fullStr | The Effect of Treatment with Mesenchymal Stem Cells on HbA1c and Insulin Requirement in Diabetic Patients: A Systematic Review and Meta-analysis |
| title_full_unstemmed | The Effect of Treatment with Mesenchymal Stem Cells on HbA1c and Insulin Requirement in Diabetic Patients: A Systematic Review and Meta-analysis |
| title_short | The Effect of Treatment with Mesenchymal Stem Cells on HbA1c and Insulin Requirement in Diabetic Patients: A Systematic Review and Meta-analysis |
| title_sort | effect of treatment with mesenchymal stem cells on hba1c and insulin requirement in diabetic patients a systematic review and meta analysis |
| topic | diabetes mellitus insulin mesenchymal stem cells |
| url | http://www.ijsrdms.com/article_224002_344a3dd39c5f2107636934a8d8fd93fe.pdf |
| work_keys_str_mv | AT parsaeshraghabadshapori theeffectoftreatmentwithmesenchymalstemcellsonhba1candinsulinrequirementindiabeticpatientsasystematicreviewandmetaanalysis AT maryamfathi theeffectoftreatmentwithmesenchymalstemcellsonhba1candinsulinrequirementindiabeticpatientsasystematicreviewandmetaanalysis AT parsaeshraghabadshapori effectoftreatmentwithmesenchymalstemcellsonhba1candinsulinrequirementindiabeticpatientsasystematicreviewandmetaanalysis AT maryamfathi effectoftreatmentwithmesenchymalstemcellsonhba1candinsulinrequirementindiabeticpatientsasystematicreviewandmetaanalysis |